A pilot study of the comparative efficacy of 100 Hz magnetic seizure therapy and electroconvulsive therapy in persistent depression

Paul B. Fitzgerald, Kate E. Hoy, David Elliot, Susan McQueen, Lenore E. Wambeek, Leo Chen, Anne Maree Clinton, Glenn Downey, Zafiris J. Daskalakis

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: Magnetic seizure therapy (MST) is a novel brain stimulation technique that uses a high-powered transcranial magnetic stimulation device to produce therapeutic seizures. Preliminary MST studies have found antidepressant effects in the absence of cognitive side effects but its efficacy compared to electroconvulsive therapy (ECT) remains unclear. The aim of this study was to investigate the therapeutic efficacy and cognitive profile of MST compared to standard right unilateral ECT treatment. Methods: Thirty-seven patients completed a course of at least nine ECT or MST treatments in a randomized double-blind protocol. Assessments of depression severity and cognition were performed before and after treatment. Results: No difference in the antidepressant effectiveness between the treatments was seen across any of the clinical outcome measures, although the overall response rates in both groups were quite low. In regards to cognition, following MST there were significant improvements in tests of psychomotor speed, verbal memory, and cognitive inhibition, with no reductions in cognitive performance. Following ECT there was significant improvement in only one of the cognitive inhibition tasks. With respect to the between-group comparisons, the MST group showed a significantly greater improvement on psychomotor speed than ECT. Conclusions: MST showed similar efficacy to right unilateral ECT in patients with treatment-resistant depression without cognitive side effects but in a sample that was only of sufficient size to demonstrate relatively large differences in response between the two groups. Future research should aim to optimize the methods of MST administration and compare its efficacy to ECT in large randomized controlled trials.

Original languageEnglish
Pages (from-to)393-401
Number of pages9
JournalDepression and Anxiety
Volume35
Issue number5
DOIs
Publication statusPublished - 1 May 2018

Keywords

  • antidepressants
  • brain stimulation
  • clinical trials
  • depression
  • ECT

Cite this

Fitzgerald, Paul B. ; Hoy, Kate E. ; Elliot, David ; McQueen, Susan ; Wambeek, Lenore E. ; Chen, Leo ; Clinton, Anne Maree ; Downey, Glenn ; Daskalakis, Zafiris J. / A pilot study of the comparative efficacy of 100 Hz magnetic seizure therapy and electroconvulsive therapy in persistent depression. In: Depression and Anxiety. 2018 ; Vol. 35, No. 5. pp. 393-401.
@article{da2443c24c3347aaa1819daf3e05ae67,
title = "A pilot study of the comparative efficacy of 100 Hz magnetic seizure therapy and electroconvulsive therapy in persistent depression",
abstract = "Background: Magnetic seizure therapy (MST) is a novel brain stimulation technique that uses a high-powered transcranial magnetic stimulation device to produce therapeutic seizures. Preliminary MST studies have found antidepressant effects in the absence of cognitive side effects but its efficacy compared to electroconvulsive therapy (ECT) remains unclear. The aim of this study was to investigate the therapeutic efficacy and cognitive profile of MST compared to standard right unilateral ECT treatment. Methods: Thirty-seven patients completed a course of at least nine ECT or MST treatments in a randomized double-blind protocol. Assessments of depression severity and cognition were performed before and after treatment. Results: No difference in the antidepressant effectiveness between the treatments was seen across any of the clinical outcome measures, although the overall response rates in both groups were quite low. In regards to cognition, following MST there were significant improvements in tests of psychomotor speed, verbal memory, and cognitive inhibition, with no reductions in cognitive performance. Following ECT there was significant improvement in only one of the cognitive inhibition tasks. With respect to the between-group comparisons, the MST group showed a significantly greater improvement on psychomotor speed than ECT. Conclusions: MST showed similar efficacy to right unilateral ECT in patients with treatment-resistant depression without cognitive side effects but in a sample that was only of sufficient size to demonstrate relatively large differences in response between the two groups. Future research should aim to optimize the methods of MST administration and compare its efficacy to ECT in large randomized controlled trials.",
keywords = "antidepressants, brain stimulation, clinical trials, depression, ECT",
author = "Fitzgerald, {Paul B.} and Hoy, {Kate E.} and David Elliot and Susan McQueen and Wambeek, {Lenore E.} and Leo Chen and Clinton, {Anne Maree} and Glenn Downey and Daskalakis, {Zafiris J.}",
year = "2018",
month = "5",
day = "1",
doi = "10.1002/da.22715",
language = "English",
volume = "35",
pages = "393--401",
journal = "Depression and Anxiety",
issn = "1091-4269",
publisher = "John Wiley & Sons",
number = "5",

}

A pilot study of the comparative efficacy of 100 Hz magnetic seizure therapy and electroconvulsive therapy in persistent depression. / Fitzgerald, Paul B.; Hoy, Kate E.; Elliot, David; McQueen, Susan; Wambeek, Lenore E.; Chen, Leo; Clinton, Anne Maree; Downey, Glenn; Daskalakis, Zafiris J.

In: Depression and Anxiety, Vol. 35, No. 5, 01.05.2018, p. 393-401.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - A pilot study of the comparative efficacy of 100 Hz magnetic seizure therapy and electroconvulsive therapy in persistent depression

AU - Fitzgerald, Paul B.

AU - Hoy, Kate E.

AU - Elliot, David

AU - McQueen, Susan

AU - Wambeek, Lenore E.

AU - Chen, Leo

AU - Clinton, Anne Maree

AU - Downey, Glenn

AU - Daskalakis, Zafiris J.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Background: Magnetic seizure therapy (MST) is a novel brain stimulation technique that uses a high-powered transcranial magnetic stimulation device to produce therapeutic seizures. Preliminary MST studies have found antidepressant effects in the absence of cognitive side effects but its efficacy compared to electroconvulsive therapy (ECT) remains unclear. The aim of this study was to investigate the therapeutic efficacy and cognitive profile of MST compared to standard right unilateral ECT treatment. Methods: Thirty-seven patients completed a course of at least nine ECT or MST treatments in a randomized double-blind protocol. Assessments of depression severity and cognition were performed before and after treatment. Results: No difference in the antidepressant effectiveness between the treatments was seen across any of the clinical outcome measures, although the overall response rates in both groups were quite low. In regards to cognition, following MST there were significant improvements in tests of psychomotor speed, verbal memory, and cognitive inhibition, with no reductions in cognitive performance. Following ECT there was significant improvement in only one of the cognitive inhibition tasks. With respect to the between-group comparisons, the MST group showed a significantly greater improvement on psychomotor speed than ECT. Conclusions: MST showed similar efficacy to right unilateral ECT in patients with treatment-resistant depression without cognitive side effects but in a sample that was only of sufficient size to demonstrate relatively large differences in response between the two groups. Future research should aim to optimize the methods of MST administration and compare its efficacy to ECT in large randomized controlled trials.

AB - Background: Magnetic seizure therapy (MST) is a novel brain stimulation technique that uses a high-powered transcranial magnetic stimulation device to produce therapeutic seizures. Preliminary MST studies have found antidepressant effects in the absence of cognitive side effects but its efficacy compared to electroconvulsive therapy (ECT) remains unclear. The aim of this study was to investigate the therapeutic efficacy and cognitive profile of MST compared to standard right unilateral ECT treatment. Methods: Thirty-seven patients completed a course of at least nine ECT or MST treatments in a randomized double-blind protocol. Assessments of depression severity and cognition were performed before and after treatment. Results: No difference in the antidepressant effectiveness between the treatments was seen across any of the clinical outcome measures, although the overall response rates in both groups were quite low. In regards to cognition, following MST there were significant improvements in tests of psychomotor speed, verbal memory, and cognitive inhibition, with no reductions in cognitive performance. Following ECT there was significant improvement in only one of the cognitive inhibition tasks. With respect to the between-group comparisons, the MST group showed a significantly greater improvement on psychomotor speed than ECT. Conclusions: MST showed similar efficacy to right unilateral ECT in patients with treatment-resistant depression without cognitive side effects but in a sample that was only of sufficient size to demonstrate relatively large differences in response between the two groups. Future research should aim to optimize the methods of MST administration and compare its efficacy to ECT in large randomized controlled trials.

KW - antidepressants

KW - brain stimulation

KW - clinical trials

KW - depression

KW - ECT

UR - http://www.scopus.com/inward/record.url?scp=85040632867&partnerID=8YFLogxK

U2 - 10.1002/da.22715

DO - 10.1002/da.22715

M3 - Article

VL - 35

SP - 393

EP - 401

JO - Depression and Anxiety

JF - Depression and Anxiety

SN - 1091-4269

IS - 5

ER -